Effects of Aspirin on Endothelial Function and Hypertension

Mikhail S. Dzeshka, Alena Shantsila, Gregory Y. H. Lip

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)
245 Downloads (Pure)


Purpose of review

Endothelial dysfunction is intimately related to the development of various cardiovascular diseases, including hypertension, and is often used as a target for pharmacological treatment. The scope of this review is to assess effects of aspirin on endothelial function and their clinical implication in arterial hypertension.

Recent findings

Emerging data indicate the role of platelets in the development of vascular inflammation due to the release of proinflammatory mediators, for example, triggered largely by thromboxane. Vascular inflammation further promotes oxidative stress, diminished synthesis of vasodilators, proaggregatory and procoagulant state. These changes translate into vasoconstriction, impaired circulation and thrombotic complications. Aspirin inhibits thromboxane synthesis, abolishes platelets activation and acetylates enzymes switching them to the synthesis of anti-inflammatory substances.


Aspirin pleiotropic effects have not been fully elucidated yet. In secondary prevention studies, the decrease in cardiovascular events with aspirin outweighs bleeding risks, but this is not the case in primary prevention settings. Ongoing trials will provide more evidence on whether to expand the use of aspirin or stay within current recommendations.
Original languageEnglish
Article number83
JournalCurrent hypertension reports
Issue number11
Early online date27 Oct 2016
Publication statusPublished - 1 Nov 2016


Dive into the research topics of 'Effects of Aspirin on Endothelial Function and Hypertension'. Together they form a unique fingerprint.

Cite this